Anti-Aging & Growth Hormone
CJC-1295 / Ipamorelin
A dual growth-hormone secretagogue pairing used to support recovery, lean mass, deeper sleep, and everyday vitality
from $329/mo
What it is
A considered protocol.
CJC-1295 and Ipamorelin are two peptides often compounded together as a growth-hormone secretagogue pairing. Together they are used to support the body's own release of growth hormone, which patients pursue for recovery, lean muscle, sleep quality, and a sense of vitality. At Orvo Health, this pairing is reviewed individually by a licensed U.S. provider and compounded in a U.S. pharmacy before being delivered discreetly to your door.
How it works
The mechanism, plainly.
CJC-1295 and Ipamorelin work on two complementary parts of the growth-hormone pathway, which is why they are often paired.
A steady signal
CJC-1295 is a growth-hormone-releasing hormone analog studied for how it may encourage the pituitary to release growth hormone in a more sustained way.
A gentle pulse
Ipamorelin is a selective secretagogue studied for how it may prompt natural growth-hormone pulses while aiming to leave other hormones largely undisturbed.
Working together
Combined, the two are intended to support the body's own rhythm of growth-hormone release rather than replace it. Individual responses vary.
Candidacy
A considered fit, not a funnel.
This pairing may suit adults exploring physician-guided support for recovery, body composition, and sleep as part of a healthy-aging routine.
- Adults focused on recovery and training
- Those seeking sleep and vitality support
- People wanting physician-guided GH-axis support
- Anyone pregnant, breastfeeding, or planning pregnancy
- Those with current or prior cancer
- Anyone with a pituitary disorder
Your concierge support
A licensed clinician, matched to you.
Every peptide protocol is coordinated end to end by our licensed care team — reviewed individually, adjusted as you go, and never handed off to a rotating call center.
- 01Compounded medication
- Prepared by partner compounding pharmacies and shipped on a structured cadence.
- 02Dedicated provider
- Every interaction is coordinated directly by our licensed care team — not a rotating callcenter.
- 03Provider-directed dosing
- Titration and adjustments at every transition under expert clinical supervision.
- 04Direct message access
- Reach your provider directly between scheduled check-ins via your secure patient portal.
- 05Structured check-ins
- Cadenced reviews to keep your protocol and overall care plan calibrated to your response.
- 06Discreet direct delivery
- Temperature-controlled, unmarked packaging delivered direct to your door.
Clinical safety
No therapy is right for everyone.
Common side effects
Reported effects are generally mild and may include temporary injection-site redness, swelling, or water retention, along with occasional headache or flushing. Your response is monitored by a licensed physician throughout care.
Who should not use it
This pairing is not appropriate during pregnancy, breastfeeding, or when planning pregnancy, for anyone with current or prior cancer, or for those with a pituitary disorder, and it is used with caution alongside insulin, corticosteroids, thyroid medication, estrogen or progesterone, or somatostatin. Your full medical history is reviewed before any prescription is authorized.
Orvo Health protocols are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — supervised by your provider — and delivered direct to your door.
Begin assessment
CJC-1295 / Ipamorelin begins with a short assessment.
A licensed provider reviews every order. If it's right for you, your protocol is compounded by a partner U.S. pharmacy and delivered discreetly to your door.